BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21409528)

  • 1. Non-steroidal anti-inflammatory drug and aspirin use and the risk of head and neck cancer: a systematic review.
    Wilson JC; Anderson LA; Murray LJ; Hughes CM
    Cancer Causes Control; 2011 May; 22(5):803-10. PubMed ID: 21409528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-steroidal anti-inflammatory drugs and the risk of head and neck cancer: A case-control analysis.
    Becker C; Wilson JC; Jick SS; Meier CR
    Int J Cancer; 2015 Nov; 137(10):2424-31. PubMed ID: 25974157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of nonsteroidal anti-inflammatory drugs and aspirin use and the risk of head and neck cancers: a meta-analysis of observational studies.
    Tang L; Hu H; Liu H; Jian C; Wang H; Huang J
    Oncotarget; 2016 Oct; 7(40):65196-65207. PubMed ID: 27533449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: A systematic review.
    Saka Herrán C; Jané-Salas E; Estrugo Devesa A; López-López J
    Oral Oncol; 2018 Oct; 85():68-81. PubMed ID: 30220322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-steroidal anti-inflammatory drug and aspirin use and the risk of head and neck cancer.
    Wilson JC; Murray LJ; Hughes CM; Black A; Anderson LA
    Br J Cancer; 2013 Mar; 108(5):1178-81. PubMed ID: 23449358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head and neck cancer and non-steroidal anti-inflammatory drugs: Systematic review and meta-analysis.
    Saka-Herrán C; Jané-Salas E; Estrugo-Devesa A; López-López J
    Head Neck; 2021 May; 43(5):1664-1682. PubMed ID: 33682986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of nonaspirin nonsteroidal anti-inflammatory drugs and risk of head and neck cancer: A nationwide case-control study.
    de la Cour CD; Dehlendorff C; Aalborg GL; von Buchwald C; Friis S; Verdoodt F; Kjaer SK
    Int J Cancer; 2020 Apr; 146(8):2139-2146. PubMed ID: 31265123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose aspirin use and risk of head and neck cancer-A Danish nationwide case-control study.
    de la Cour CD; Verdoodt F; Aalborg GL; von Buchwald C; Friis S; Dehlendorff C; Kjaer SK
    Br J Clin Pharmacol; 2021 Mar; 87(3):1561-1567. PubMed ID: 32737902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-steroidal anti-inflammatory drug use and risk of endometrial cancer: A systematic review and meta-analysis of observational studies.
    Verdoodt F; Friis S; Dehlendorff C; Albieri V; Kjaer SK
    Gynecol Oncol; 2016 Feb; 140(2):352-8. PubMed ID: 26701413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level.
    Veitonmäki T; Tammela TL; Auvinen A; Murtola TJ
    Eur J Cancer; 2013 Mar; 49(4):938-45. PubMed ID: 23079475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin and other non-steroidal anti-inflammatory drug prescriptions and survival after the diagnosis of head and neck and oesophageal cancer.
    Macfarlane TV; Murchie P; Watson MC
    Cancer Epidemiol; 2015 Dec; 39(6):1015-22. PubMed ID: 26590503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.
    Cook JC; Jacobson CF; Gao F; Tassinari MS; Hurtt ME; DeSesso JM
    Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-aspirin non-steroidal anti-inflammatory drugs for the primary chemoprevention of non-gastrointestinal cancer: summary of evidence.
    Silva MT; Galvao TF; Zimmerman IR; Pereira MG; Lopes LC
    Curr Pharm Des; 2012; 18(26):4047-70. PubMed ID: 22632754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can oral nonsteroidal antiinflammatory drugs play a role in the prevention of basal cell carcinoma? A systematic review and metaanalysis.
    Muranushi C; Olsen CM; Green AC; Pandeya N
    J Am Acad Dermatol; 2016 Jan; 74(1):108-119.e1. PubMed ID: 26433247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis.
    Corley DA; Kerlikowske K; Verma R; Buffler P
    Gastroenterology; 2003 Jan; 124(1):47-56. PubMed ID: 12512029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk: A Population-Based, Case-Control Study.
    Friis S; Riis AH; Erichsen R; Baron JA; Sørensen HT
    Ann Intern Med; 2015 Sep; 163(5):347-55. PubMed ID: 26302241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and non-steroidal anti-inflammatory drugs use reduce gastric cancer risk: A dose-response meta-analysis.
    Huang XZ; Chen Y; Wu J; Zhang X; Wu CC; Zhang CY; Sun SS; Chen WJ
    Oncotarget; 2017 Jan; 8(3):4781-4795. PubMed ID: 27902474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin and non-steroidal anti-inflammatory drug use and the risk of upper aerodigestive tract cancer.
    Macfarlane TV; Lefevre K; Watson MC
    Br J Cancer; 2014 Oct; 111(9):1852-9. PubMed ID: 25211662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-aspirin NSAIDs and head and neck cancer mortality in a Danish nationwide cohort study.
    de la Cour CD; Dehlendorff C; von Buchwald C; Garset-Zamani M; Grønhøj C; Carlander AF; Friis S; Kjaer SK
    Cancer Epidemiol; 2022 Apr; 77():102121. PubMed ID: 35183905
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.